A Phase 2 Study Investigating the Efficacy and Safety of HSK44459 Tablet Administered to Participants With Atopic Dermatitis
Latest Information Update: 04 Jun 2025
At a glance
- Drugs HSK 44459 (Primary)
- Indications Atopic dermatitis
- Focus Therapeutic Use
- Sponsors Haisco Pharmaceutical Group
Most Recent Events
- 04 Jun 2025 New trial record